A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive ...

NeoGenomics, Inc. NEO recently announced the availability of its new pan-solid tumor assay, PanTracer Pro, designed to help ...

On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer ...

Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...

Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four cancers. The enzyme, N4BP2, breaks apart DNA trapped in tiny cellular ...

Cancer is no longer seen as a single genetic error but as a complex, multi-layered disease shaped by DNA mutations, epigenetic changes and even patterns in medical images. New research at ...

Genomics is collaborating with PharosAI and leading UK institutions to build a large multimodal cancer dataset using its Xenium spatial platform. The project will use decades of NHS cancer samples to ...

CCNSB researchers at IIIT Hyderabad focus on genomics, epigenetics and AI for cancer detection and treatment: Our Bureau, Bengaluru Monday, February 16, 2026, 15:50 Hrs [IST] Rese ...

Cancer genomics pioneer Prof Sir Mike Stratton has been awarded the 2026 Jessie Stevenson Kovalenko Medal by the Council of ...

The project focuses on increasing the diversity of genetic data and improving outcomes of conditions such as hypertension, diabetes, and triple-negative breast cancer.

JRHEF has proudly donated $25,000 to PMCF in support of the OurGenes Study, Canada’s first population-based genetic ...

First Ascent Biomedical Opens FPM Cancer Lab in Miami; Welcomes World-Class Clinical Leadership Miami lab is now accepting patient and physician referrals. Eligible Florida residents and colorectal ...